Senegal

in page functions
Total population (2012)13,107,945
Birth cohort (2012)475,941
Surviving Infants (surviving to 1 year per year, 2012)451,971
Infant mortality rate (deaths < 1 year per 1000 births, 2012)50.37/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)85.92/1000
World Bank Index, IDA (2012)3.68
Gross Nation Income (per capita US$, 2010)1,090
Co-financing status (2012)Intermediate
No. of districts/territories (2009)65

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Senegal

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
200220032004200520062007200820092010201120122013201420152016
Health System Strengthening (HSS)$3,585,500$3,585,500$1,806,75050%
HepB mono (NVS)$588,743$588,743$588,743100%
Immunisation Services Support (ISS)$2,605,740$2,816,240$2,605,740100%
Injection Safety Support (INS)$619,474$619,474$619,474100%
Meningitis A - campaign (NVS)$3,054,000$3,054,000
Operational Support$1,185,000$1,185,000
Penta (NVS)$33,790,937$41,658,437$32,722,94997%
Pneumo (NVS)$6,210,250$37,419,858
Vaccine Introduction Grant$251,000$251,000$100,00040%
Total$51,890,644$91,178,252$38,443,656

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)70%
DTP3 - Official country estimates (2010)70%
M:F sex ratio at birth (2012)1.03%
Household survey: DTP3 coverage for male (2010)84.30%
Household survey: DTP3 coverage for female (2010)80.70%
Household survey: Last DTP3 survey (2010)83%
% districts achieving > 80% DTP3 coverage (2010)3%
% districts achieving < 50% DTP3 coverage (2010)62%
MCV WHO/UNICEF estimates (2010)60%
Polio WHO/UNICEF estimates (2010)70%

Breakdown of support

CSO, HSS & ISS supportVaccine support
13% 87%
$5,131,964 $33,311,692

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

21 February 2012

Nigeria MenA

Q and A on Nigeria’s introduction of MenAfriVac

Interview with Muhammad Sani Adamu, Head of Accelerated Disease Control in Nigeria’s National Primary Health Care Development Agency, who played a key role in rolling out the new vaccine against meningitis A, MenAfriVac, to Nigeria’s northern states.

26 January 2012

Chad’s campaign against meningitis A

One of the first countries to introduce the new meningitis A vaccine (MenAfriVac), Chad ran an immunisation campaign with GAVI support in December 2011 to help eliminate the region’s devastating epidemics.

10 June 2011

Rotavirus vaccinations in Ghana

Developing countries make record demand for life-saving vaccines

A record 50 GAVI eligible countries have applied for vaccine funding from the GAVI Alliance during the organisation’s latest application round, reported GAVI officials today.

close icon

modal window here